Molecular & Genetic Markers
Next-generation sequencing
Next-generation sequencing is a technology that rapidly reads many genes at once, used to detect the mutations that classify and guide glioma treatment.
In short: Next-generation sequencing
- It rapidly reads many genes at once.
- It detects mutations relevant to diagnosis and treatment.
- It can identify targetable changes and guide therapy.
- It is increasingly part of glioma evaluation.
What it is
Next-generation sequencing (NGS) is a technology that rapidly reads the genetic code of many genes simultaneously. In gliomas, it is used to detect the mutations and molecular changes that classify the tumor and guide treatment.
Understanding Next-generation sequencing
Rather than testing one gene at a time, next-generation sequencing can analyze a large panel of genes (or even the entire coding genome) in a single test. This efficiency makes it well suited to gliomas, where multiple molecular features matter — such as IDH, TERT, EGFR, BRAF, and many others. NGS can confirm the diagnosis, detect targetable changes (such as BRAF V600E, opening the option of targeted drugs), and identify features relevant to clinical trial eligibility. As molecular features have become central to glioma care, NGS has become an increasingly standard part of evaluation, particularly at specialized centers. It complements other tests such as immunohistochemistry and methylation profiling. Understanding next-generation sequencing clarifies the technology that reads many genes at once to inform glioma diagnosis and treatment.
Why it matters
Understanding next-generation sequencing helps patients and families see how a single test can read many genes at once — detecting the mutations that classify the tumor, reveal targetable changes, and inform treatment and trial options.
Common questions
What is next-generation sequencing?
A technology that rapidly reads many genes at once.
What is it used for?
Detecting mutations that classify and guide glioma treatment.
Can it find targetable changes?
Yes — such as BRAF V600E, which can guide therapy.
Bottom line
Next-generation sequencing rapidly reads many genes at once to detect the mutations that classify gliomas, reveal targetable changes, and guide treatment.
Browse all 265 Glioma definitions
Read the Glioma patient guides
Not sure which page you need? Put words to it with the symptom navigator